NYSE:NVOPharmaceuticals
Does Novo Nordisk’s Recent Recovery Signal More Gains Ahead in 2025?
Thinking about what to do with Novo Nordisk's stock right now? You are definitely not alone. Whether you already own shares or are eyeing a new position, the past year has been a real rollercoaster. After peaking with impressive gains over the last five years, up nearly 84%, the stock has dropped significantly in 2024, with year-to-date returns down more than 34%. Despite the rough patch, the action in recent weeks shows signs of renewed optimism, with the stock bouncing back by about 8.7%...